BR9807887B1 - complexos de estabilizados quanto à atividade e imobilizados de antagonistas de lhrh, processo para preparação de preparados de hormÈnio de peptìdeo a partir dos referidos complexos, bem como medicamentos que os contêm. - Google Patents

complexos de estabilizados quanto à atividade e imobilizados de antagonistas de lhrh, processo para preparação de preparados de hormÈnio de peptìdeo a partir dos referidos complexos, bem como medicamentos que os contêm.

Info

Publication number
BR9807887B1
BR9807887B1 BRPI9807887-9A BR9807887A BR9807887B1 BR 9807887 B1 BR9807887 B1 BR 9807887B1 BR 9807887 A BR9807887 A BR 9807887A BR 9807887 B1 BR9807887 B1 BR 9807887B1
Authority
BR
Brazil
Prior art keywords
complexes
well
peptide hormone
medicaments containing
lhrh antagonists
Prior art date
Application number
BRPI9807887-9A
Other languages
English (en)
Other versions
BR9807887A (pt
Inventor
Juergen Engel
Wolfgang Deger
Thomas Reissmann
Guenter Losse
Wolfgang Naumann
Sandra Murgas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9807887A publication Critical patent/BR9807887A/pt
Publication of BR9807887B1 publication Critical patent/BR9807887B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI9807887-9A 1997-03-26 1998-03-11 complexos de estabilizados quanto à atividade e imobilizados de antagonistas de lhrh, processo para preparação de preparados de hormÈnio de peptìdeo a partir dos referidos complexos, bem como medicamentos que os contêm. BR9807887B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712718A DE19712718C2 (de) 1997-03-26 1997-03-26 Immobilisierte und aktivitätsstabilisierte Komplexe von LHRH-Antagonisten und Verfahren zu deren Herstellung
PCT/EP1998/001398 WO1998042381A1 (de) 1997-03-26 1998-03-11 Immobilisierte und aktivitätsstabilisierte komplexe von lhrh-antagonisten und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
BR9807887A BR9807887A (pt) 2000-02-22
BR9807887B1 true BR9807887B1 (pt) 2010-05-18

Family

ID=7824698

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9807887-9A BR9807887B1 (pt) 1997-03-26 1998-03-11 complexos de estabilizados quanto à atividade e imobilizados de antagonistas de lhrh, processo para preparação de preparados de hormÈnio de peptìdeo a partir dos referidos complexos, bem como medicamentos que os contêm.

Country Status (27)

Country Link
US (2) US6022860A (pt)
EP (1) EP0981377B1 (pt)
JP (1) JP4180120B2 (pt)
CN (1) CN1150943C (pt)
AR (1) AR012186A1 (pt)
AT (1) ATE249245T1 (pt)
AU (1) AU747808B2 (pt)
BR (1) BR9807887B1 (pt)
CA (1) CA2285054C (pt)
CZ (1) CZ300755B6 (pt)
DE (2) DE19712718C2 (pt)
DK (1) DK0981377T3 (pt)
ES (1) ES2206912T3 (pt)
HK (1) HK1025255A1 (pt)
HU (1) HUP0002059A3 (pt)
IL (1) IL131181A (pt)
NO (1) NO327404B1 (pt)
NZ (1) NZ337343A (pt)
PL (1) PL190090B1 (pt)
PT (1) PT981377E (pt)
RU (1) RU2207151C2 (pt)
SK (1) SK284461B6 (pt)
TR (1) TR199902168T2 (pt)
TW (1) TW520288B (pt)
UA (1) UA69381C2 (pt)
WO (1) WO1998042381A1 (pt)
ZA (1) ZA982225B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070185032A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE69912422T2 (de) * 1998-04-23 2004-08-19 Zentaris Gmbh Methode zur behandlung von fruchtbarkeitsstörungen
CO5160256A1 (es) * 1999-02-08 2002-05-30 Zentaris Ag Sales de peptidos farmaceuticamente activos para la liberacion sostenida y proceso de produccion
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US7037889B2 (en) 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
PE20020908A1 (es) * 2001-03-21 2002-10-26 Cell Therapeutics Inc Produccion recombinante de polimeros polianionicos y uso de de los mismos
US7015253B2 (en) * 2001-07-10 2006-03-21 American Medical Systems, Inc. Regimen for treating prostate tissue and surgical kit for use in the regimen
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
US8093207B2 (en) * 2005-12-09 2012-01-10 Unigene Laboratories, Inc. Fast-acting oral peptide pharmaceutical products
US9232959B2 (en) 2007-01-02 2016-01-12 Aquabeam, Llc Multi fluid tissue resection methods and devices
JP5369336B2 (ja) 2007-01-02 2013-12-18 アクアビーム エルエルシー 前立腺の疾患を治療するための侵襲性が最小である方法及びデバイス
US8814921B2 (en) * 2008-03-06 2014-08-26 Aquabeam Llc Tissue ablation and cautery with optical energy carried in fluid stream
US9848904B2 (en) 2009-03-06 2017-12-26 Procept Biorobotics Corporation Tissue resection and treatment with shedding pulses
US8853354B2 (en) 2009-03-27 2014-10-07 Kagoshima University Polyion complex comprising hydrophobized polyamino acid and use of the same
WO2016004071A1 (en) 2014-06-30 2016-01-07 Procept Biorobotics Corporation Fluid jet tissue resection and cold coagulation (aquablation) methods and apparatus
CN104203078B (zh) 2012-02-29 2018-04-20 普罗赛普特生物机器人公司 自动化图像引导的组织切除和处理
CN105431096B (zh) 2013-02-14 2018-07-31 普罗赛普特生物机器人公司 液体消融液体束眼外科手术的方法和装置
BR112016005036A2 (pt) 2013-09-06 2020-04-07 Procept Biorobotics Corp aparelho para ressecção de tecido guiada por imagem automatizada
CN107072591B (zh) 2014-09-05 2021-10-26 普罗赛普特生物机器人公司 与靶器官图像的治疗映射结合的医师控制的组织切除

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE257197C (pt) *
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
DD257197A1 (de) * 1987-01-28 1988-06-08 Univ Dresden Tech Verfahren zur herstellung von immobilisierten, in ihrer biologischen aktivitaet stabilisierten und in ihren pharmakologischen eigenschaften modifizierten insulinpraeparationen
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
DD269785A1 (de) * 1988-02-08 1989-07-12 Univ Dresden Tech Verfahren zur herstellung von aktivitaetsstabilisierten und in ihren pharmakologischen eigenschaften modifizierten peptidderivaten
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
ATE131042T1 (de) * 1990-04-25 1995-12-15 Hoechst Ag Pharmakologische zubereitung, enthaltend polyelektrolytkomplexe in mikropartikulärer form und mindestens einen wirkstoff.
DD299265A5 (de) * 1990-09-11 1992-04-09 Technische Universitaet Dresden,De Verfahren zur herstellung von immobilisierten und aktivitaetsstabilisierten praeparaten des gonadotropin-releasing-hormons oder dessen analoga mit polyaminosaeuren
US5834520A (en) * 1992-10-08 1998-11-10 Asta-Medica Aktiengesellschaft Container for injectable mesna solutions
WO1994011015A1 (en) * 1992-11-12 1994-05-26 Molecular Dynamics, Inc. Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US5449720A (en) * 1993-05-24 1995-09-12 Biotech Australia Pty Limited Amplification of the VB12 uptake system using polymers
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides

Also Published As

Publication number Publication date
DE59809575D1 (de) 2003-10-16
TW520288B (en) 2003-02-11
BR9807887A (pt) 2000-02-22
WO1998042381A1 (de) 1998-10-01
CA2285054C (en) 2007-08-21
US6054555A (en) 2000-04-25
HK1025255A1 (en) 2000-11-10
NO994665D0 (no) 1999-09-24
RU2207151C2 (ru) 2003-06-27
ES2206912T3 (es) 2004-05-16
HUP0002059A3 (en) 2001-02-28
PL190090B1 (pl) 2005-10-31
IL131181A0 (en) 2001-01-28
SK284461B6 (sk) 2005-04-01
TR199902168T2 (xx) 1999-12-21
CZ337199A3 (cs) 2000-03-15
CZ300755B6 (cs) 2009-08-05
PT981377E (pt) 2004-02-27
EP0981377A1 (de) 2000-03-01
SK131699A3 (en) 2000-05-16
ATE249245T1 (de) 2003-09-15
EP0981377B1 (de) 2003-09-10
AU6920798A (en) 1998-10-20
AU747808B2 (en) 2002-05-23
AR012186A1 (es) 2000-09-27
DK0981377T3 (da) 2003-11-10
JP2001520662A (ja) 2001-10-30
ZA982225B (en) 1998-04-03
DE19712718C2 (de) 1999-09-23
CN1249691A (zh) 2000-04-05
NO327404B1 (no) 2009-06-22
CA2285054A1 (en) 1998-10-01
NO994665L (no) 1999-09-24
IL131181A (en) 2004-09-27
PL335830A1 (en) 2000-05-22
US6022860A (en) 2000-02-08
JP4180120B2 (ja) 2008-11-12
HUP0002059A2 (hu) 2000-10-28
DE19712718A1 (de) 1998-10-01
NZ337343A (en) 2001-10-26
CN1150943C (zh) 2004-05-26
UA69381C2 (uk) 2004-09-15

Similar Documents

Publication Publication Date Title
BR9807887B1 (pt) complexos de estabilizados quanto à atividade e imobilizados de antagonistas de lhrh, processo para preparação de preparados de hormÈnio de peptìdeo a partir dos referidos complexos, bem como medicamentos que os contêm.
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9911914B1 (pt) n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
BR9804504B1 (pt) isoquinolina-3-carboxamidas substituÍdas, processo para a preparaÇço das mesmas e medicamento.
DE69830095D1 (de) Pharmazeutischer, kosmetischer oder dermo-pharmazeutischer Patch zur Verabreichung mehrerer verschiedenartiger Aktivstoffe
DK0876815T3 (da) Lægemiddel-indgivelsessystem for to eller flere aktive stoffer
NO994837D0 (no) Intravesikal medikamentavleveringssystem
PT1003478E (pt) Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois
FR08C0025I2 (fr) Heterocycles bicycliques disubstitues, production et utilisation comme medicaments
ATE77338T1 (de) Druckkapsel fuer spritzbehaelter, und spritzbehaelter, welcher eine solche kapsel anwendet.
PT89506B (pt) Processo para a preparacao de derivados de quinazolina com actividade fungicida, insecticida e miticida
DE69915235D1 (de) Implantierbares system, das medikamente freisetzende zellen enthält, für eine bedarfsgerechte, lokale verabreichung von medikamenten
BR9611016A (pt) Preparacões inseticidas microencapsuladas e um processo para preparação das mesmas
BR9712808B1 (pt) indol-3-glioxilamidas n-substituìdas, bem como aplicação, medicamento e processo para a preparação das mesmas.
PT730864E (pt) Medicamento para tratar doencas inflamatorias cardiacas
NO973850L (no) Fenylsubstituerte alkenylkarboksylsyreguanidider, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
BRPI9915208B8 (pt) preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
FR2767121B1 (fr) Distributeur de medicaments
BR9808255B1 (pt) amidas de ácido aminossalicìlico substituìdas com efeito fungicida, bem como processo para a preparação e uso das mesmas, composições praguicidas, processo para a preparação das mesmas e para combater pragas.
AR002982A1 (es) Benzonitrilos y benzofluoruros, un procedimiento para prepararlos, su empleo para preparar médicamentos, un médicamento hecho a base de estos compuestos, las preparaciónes farmacéuticas que los contienen y un procedimiento para obtener estas preparaciónes farmacéuticas.
PT1033990E (pt) 21-hidroxi-6,19-oxidoprogesterona (21oh-6op) e a sua utilizacao como medicamento para tratar o excesso de glucocorticoides
PT903339E (pt) Bifenilsulfonilcianamidas processos para a sua preparacao e sua utilizacao como medicamentos
NO975214L (no) 3-amidokromanylsulfonyl(tio)ureaer, fremgangsmÕter for deres fremstilling, deres anvendelse og farmas÷ytiske preparater inneholdende disse
DE69824582D1 (de) Chinolin- und naphthalincarboxamide, pharmazeutische zubereitungen und verfahren zur hemmung von calpain

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ZENTARIS AG (DE)

B25A Requested transfer of rights approved

Owner name: BLITZ F02-570 GMBH (DE)

Free format text: TRANSFERIDO POR FUSAO DE: ZENTARIS AG

B25D Requested change of name of applicant approved

Owner name: ZENTARIS GMBH (DE)

Free format text: ALTERADO DE: BLITZ F02-570 GMBH

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/05/2010, OBSERVADAS AS CONDICOES LEGAIS.

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/09 (2006.01), A61K 47/64 (2017.0

B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 13A, 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A E 22A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.